Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hexaxim Booster Study in Mexican Toddlers
NCT00654901Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2008
- Primary completion
- May 2009
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hexaxim in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by Sanofi. Started Mar 2008; status: completed.
02
Drugs
hexaxim
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT00654901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654901.